Growblox Sciences
Las Vegas, US
Biotech
Founders & leadership
JP
John PossExecutive Officer
CE
Craig EllinsExecutive Officer, Director
AS
Andrea Small-HowardExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$75KraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)$25KraisedJun 2022 · 1 investors · Biotechnology
Rule 506(b)$240KraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)$2MraisedOct 2019 · 21 investors · Biotechnology
Rule 506(b)$2.9MraisedOct 2019 · 17 investors · Biotechnology
Rule 506(b)$7.2MraisedOct 2019 · 60 investors · Biotechnology
Rule 506(b)$5MraisedOct 2018 · 28 investors · Biotechnology
Rule 506(b)$3.9MraisedNov 2017 · 48 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.